Position in APLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,011,500
New position
Shares Held
50,000
first reported quarter
Ownership
0.039%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#144
of 320 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026TPG GP A, LLC holds $371,578,392 across 6 Biotechnology names. APLS ranks #5 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SION |
Sionna Therapeutics, Inc.
|
6,494,962 | $260,383,026 | |
| 2 | BCAX |
Bicara Therapeutics Inc.
|
3,010,425 | $59,877,353 | |
| 3 | ALLO |
Allogene Therapeutics, Inc.
|
18,716,306 | $45,667,786 | |
| 4 | RLYB |
Rallybio Corp
|
378,551 | $3,395,602 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
This page
|
50,000 | $2,011,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,500 | $243,125 |
All Filings in APLS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,011,500 | 50,000 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||